These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6117651)

  • 1. A comparison of the behaviour of tablet and capsule formulations in vivo.
    Hunter E; Fell JT; Sharma H
    J Pharm Pharmacol; 1981 Sep; 33(9):617-8. PubMed ID: 6117651
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of food intake on the gastric emptying of gastric juice-resistant tablets and capsules].
    Ewe K; Press AG; Oestreicher M
    Dtsch Med Wochenschr; 1992 Feb; 117(8):287-90. PubMed ID: 1537265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous measurement of gastric emptying of the soluble and insoluble components of a formulation using a dual isotope, gamma scintigraphic technique.
    Kaus L; Sharma H; Fell JT
    J Pharm Pharmacol; 1984 Feb; 36(2):136-8. PubMed ID: 6143805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of human pharmacoscintigraphic behavior of two tablets and a capsule formulation of a high dose, poorly water soluble/highly permeable drug (efavirenz).
    Gao JZh; Hussain MA; Motheram R; Gray DA; Benedek IH; Fiske WD; Doll WJ; Sandefer E; Page RC; Digenis GA
    J Pharm Sci; 2007 Nov; 96(11):2970-7. PubMed ID: 17542016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacoscintigraphic study of three time-delayed capsule formulations in healthy male volunteers.
    McConville JT; Hodges LA; Jones T; Band JP; O'Mahony B; Lindsay B; Ross AC; Florence AJ; Stanley AJ; Humphrey MJ; Wilson CG; Stevens HN
    J Pharm Sci; 2009 Nov; 98(11):4251-63. PubMed ID: 19387976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What happens to tablets and capsules in the stomach: endoscopic comparison of disintegration and dispersion characteristics of two microencapsulated potassium formulations.
    Graham DY; Smith JL; Bouvet AA
    J Pharm Sci; 1990 May; 79(5):420-4. PubMed ID: 2352162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of formulation on oesophageal transit.
    Channer KS; Virjee JP
    J Pharm Pharmacol; 1985 Feb; 37(2):126-9. PubMed ID: 2858546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the gastrointestinal transit and disintegration behavior of floating and sinking acid-resistant capsules using a novel MRI labeling technique.
    Grimm M; Ball K; Scholz E; Schneider F; Sivert A; Benameur H; Kromrey ML; Kühn JP; Weitschies W
    Eur J Pharm Sci; 2019 Mar; 129():163-172. PubMed ID: 30639530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
    Shah J; Wesnes KA; Kovelesky RA; Henney HR
    Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
    Binnion PF
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of non-disintegrating tablet dimensions and density on their gastric emptying in fasted volunteers.
    Podczeck F; Course NC; Newton JM; Short MB
    J Pharm Pharmacol; 2007 Jan; 59(1):23-7. PubMed ID: 17227617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS).
    Christiansen ML; Holm R; Kristensen J; Kreilgaard M; Jacobsen J; Abrahamsson B; Müllertz A
    Eur J Pharm Sci; 2014 Jun; 57():164-72. PubMed ID: 24239996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Search for technological reasons to develop a capsule or a tablet formulation with respect to wettability and dissolution.
    von Orelli J; Leuenberger H
    Int J Pharm; 2004 Dec; 287(1-2):135-45. PubMed ID: 15541920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric emptying rate of drug preparations. III. Effects of size of enteric micro-capsules with mean diameters ranging from 0.1 to 1.1 mm in man.
    Sugito K; Ogata H; Goto H; Kaniwa N; Takahata H; Samejima M
    Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3343-5. PubMed ID: 1294338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug absorption and bioavailability problems of tablets and capsules].
    Cascioli D; Petrangeli B
    Boll Chim Farm; 1978 Aug; 117(8):437-51. PubMed ID: 743388
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of gastric emptying kinetics on the drug release from enteric coated pellets in fasted state: an in vitro/in vivo correlation.
    Stefanič M; Locatelli I; Vrečer F; Sever T; Mrhar A; Bogataj M
    Eur J Pharm Biopharm; 2012 Oct; 82(2):376-82. PubMed ID: 22884655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying.
    Weitschies W; Friedrich C; Wedemeyer RS; Schmidtmann M; Kosch O; Kinzig M; Trahms L; Sörgel F; Siegmund W; Horkovics-Kovats S; Schwarz F; Raneburger J; Mönnikes H
    Eur J Pharm Biopharm; 2008 Oct; 70(2):641-8. PubMed ID: 18582572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.